FDA Approves Tlando (testosterone undecanoate) for Male Hypogonadism

EWING, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc.,  (NASDAQ: ATRS) (the“Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration granted final approval for...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news